» Articles » PMID: 38699473

Multi-omics-based Investigation of Inhibitory Effect on Glioma: Regulation of Tumor and Gut Microbiota, and MEK/ERK Cascade

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2024 May 3
PMID 38699473
Authors
Affiliations
Soon will be listed here.
Abstract

Glioma, the most prevalent primary tumor of the central nervous system, is characterized by a poor prognosis and a high recurrence rate. The interplay between microbes, such as gut and tumor microbiota, and the host has underscored the significant impact of microorganisms on disease progression. , a beneficial bacterial strain found in the human and animal intestines, exhibits inhibitory effects against various diseases. However, the existing body of evidence pertaining to the influence of on glioma remains insufficient. Here, we found that reduces tumor volume and prolongs survival time in an orthotopic mouse model of glioma. Experiments elucidated that suppresses the MEK/ERK cascade. Additionally, we noted an increase in the α-diversity of the tumor microbiota, along with an augmented relative abundance of in the gut microbiota. This rise in levels within the intestine may be attributed to a concurrent increase in within the glioma. Additionally, induced alterations in serum metabolites, particularly those comprised of organonitrogen compounds. Thus, our findings showed that can suppress glioma growth by inhibiting the MEK/ERK cascade and regulating tumor, and gut microbiota, and serum metabolites in mice, indicating the promising therapeutic prospects of against glioma.

Citing Articles

The Role of the Gut Microbiota in Modulating Signaling Pathways and Oxidative Stress in Glioma Therapies.

Krawczyk A, Sladowska G, Strzalka-Mrozik B Cancers (Basel). 2025; 17(5).

PMID: 40075568 PMC: 11899293. DOI: 10.3390/cancers17050719.


Delayed Tooth Development and the Impaired Differentiation of Stem/Progenitor Cells in Incisors from Type 2 Diabetes Mice.

Kobayashi Y, Huang J, Barnett B, Falcon C, Falcon P, Hirschberg C Int J Mol Sci. 2025; 25(24.

PMID: 39769381 PMC: 11728242. DOI: 10.3390/ijms252413619.


Gut microbiota's role in glioblastoma risk, with a focus on the mediating role of metabolites.

Yan J, Li B, Luo C Front Neurol. 2024; 15:1386885.

PMID: 39022732 PMC: 11253649. DOI: 10.3389/fneur.2024.1386885.

References
1.
Pushalkar S, Hundeyin M, Daley D, Zambirinis C, Kurz E, Mishra A . The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression. Cancer Discov. 2018; 8(4):403-416. PMC: 6225783. DOI: 10.1158/2159-8290.CD-17-1134. View

2.
Suzuki T . Regulation of the intestinal barrier by nutrients: The role of tight junctions. Anim Sci J. 2020; 91(1):e13357. PMC: 7187240. DOI: 10.1111/asj.13357. View

3.
Song D, Wang X, Ma Y, Liu N, Wang H . Beneficial insights into postbiotics against colorectal cancer. Front Nutr. 2023; 10:1111872. PMC: 10036377. DOI: 10.3389/fnut.2023.1111872. View

4.
Sepich-Poore G, Zitvogel L, Straussman R, Hasty J, Wargo J, Knight R . The microbiome and human cancer. Science. 2021; 371(6536). PMC: 8767999. DOI: 10.1126/science.abc4552. View

5.
Qiao L, Yang H, Shao X, Yin Q, Fu X, Wei Q . Research Progress on Nanoplatforms and Nanotherapeutic Strategies in Treating Glioma. Mol Pharm. 2022; 19(7):1927-1951. DOI: 10.1021/acs.molpharmaceut.1c00856. View